Park City Angels is thrilled to announce that our members have made an investment in Nanocan Therapeutics Corporation https://lnkd.in/g6B4F6qy Click on these photos to learn more! #venturecapital #growth #startups #investment #parkcity #parkcityutah #Nanocan #innovation #angelinvesting
Nanocan Therapeutics Corporation
Biotechnology Research
Princeton, NJ 678 followers
An early stage biotechnology company developing nanotechnology based therapeutic medicines to treat certain cancers.
About us
Nanocan Therapeutics Corporation is a Princeton, New Jersey based early stage biotechnology company developing cutting-edge, nanotechnology based innovations for therapeutic medicines to treat certain cancers where current interventions are insufficient. The Company’s inventions deploy smart radiotherapy biomaterials (nanoparticle drones), as a drug-delivery platform. Nanocan’s nanoparticle drones can be employed to sustainably deliver different drug payloads – including immunotherapy drugs, chemotherapy drugs, and phytomedicines – precisely to disease sites or targets, with greater therapeutic efficacy. Through its partnerships with leading academic research institutions, Nanocan is rapidly developing therapies that may ultimately result in new standards of care to help improve the lives of cancer patients. Nanocan is committed to making its disruptive innovations available to cancer patients in the U.S. and globally, including Low and Middle-Income Countries (“LMICs”), starting with countries in Africa.
- Website
-
http://www.nanocan.life
External link for Nanocan Therapeutics Corporation
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Princeton, NJ
- Type
- Privately Held
- Founded
- 2020
Locations
-
Primary
Princeton, NJ, US
Employees at Nanocan Therapeutics Corporation
-
Eric Broyles
-
Paul Nguyen
Professor, Harvard Medical School; Vice-Chair for Clinical Research & Director of Genitourinary Radiation Oncology Dana-Farber/Brigham and Women's…
-
Jacques P. Walker
Entrepreneur - Investor - Catalyst - Mentor
-
Neal Kantharia
Program Manager at Nanocan Therapeutics
Updates
-
We’re thrilled to announce that Nanocan has been named a Deep Tech Pioneer by Hello Tomorrow! From thousands of applications their experts saw real potential in our solution. Come and meet us at the Hello Tomorrow Global Summit in March 2024, the cornerstone event dedicated to celebrating and accelerating deep tech innovation: connecting key people bringing solutions from lab to market and strengthening the deep tech investment network. Don’t miss out! 👉https://lnkd.in/g8keznYm